To study rhodopsin biosynthesis and transport in vivo, we engineered a fusion protein (rho-GFP) of bovine rhodopsin (rho) and green fluorescent protein (GFP). rho-GFP expressed in COS-1 cells bound 11-cis retinal, generating a pigment with spectral properties of rhodopsin (A max at 500 nm) and GFP (A max at 488 nm). rho-GFP activated transducin at 50% of the wild-type activity, whereas phosphorylation of rho-GFP by rhodopsin kinase was 10% of wild-type levels. We expressed rho-GFP in the rod photoreceptors of Xenopus laevis using the X. laevis principal opsin promoter. Like rhodopsin, rho-GFP localized to rod outer segments, indicating that rho-GFP was recognized by membrane transport mechanisms. In contrast, a rho-GFP variant lacking the Cterminal outer segment localization signal distributed to both outer and inner segment membranes. Confocal microscopy of transgenic retinas revealed that transgene expression levels varied between cells, an effect that is probably analogous to position-effect variegation. Furthermore, rho-GFP concentrations varied along the length of individual rods, indicating that expression levels varied within single cells on a daily or hourly basis. These results have implications for transgenic models of retinal degeneration and mechanisms of position-effect variegation and demonstrate the utility of rho-GFP as a probe for rhodopsin transport and temporal regulation of promoter function.
Studies of protein targeting and renewal have largely been carried out in cultured cell systems. However, cultured cells often provide only an approximation of the in vivo situation, particularly when proteins are studied in heterologous cell systems or when interactions between cell types in highly organized tissues may be critical. Here we employ an in vivo system for the study of rhodopsin targeting and renewal in an animal in which simple genetic manipulations are easily accomplished, transgenic Xenopus laevis that express a fluorescent form of rhodopsin. In developing this system, we encountered variable protein expression patterns resembling heterochromatin-associated position-effect variegation. Because of the unique mechanisms of photoreceptor outer segment growth and renewal, we obtained a novel perspective on this previously described artifact of transgenesis.
Rhodopsin is the light-sensing visual pigment of vertebrate rod photoreceptor cells, which mediate vision under dim light conditions. It consists of an apoprotein, opsin, with seven membrane-spanning domains and a covalently attached 11-cis retinal chromophore. Upon light absorption, the retinal chromophore undergoes cis-trans isomerization, eliciting a series of conformational changes that initiate intracellular signaling through the G-protein transducin, leading to closure of cation channels in the plasma membrane and hyperpolarization of the cell (1) .
Rhodopsin is found almost exclusively in the rod outer segment (ROS) 1 compartment of vertebrate rod photoreceptors. The ROS consists of a stack of membranous discs surrounded by a plasma membrane, connected to the rod cell body or inner segment (RIS) by a connecting cilium. Rhodopsin is present in ROS at enormous levels, where it constitutes greater than 90% of total membrane protein (2) at a concentration of ϳ3 mM (3, 4) . Only minor quantities of rhodopsin are found in the inner segment membranes (5) .
ROS membranes are continuously renewed in a unique manner. Newly synthesized rhodopsin-containing discs are added at the base of the ROS, near the RIS/ROS junction, and are gradually displaced toward the distal end of the ROS, where they are shed and phagocytosed by the adjacent retinal pigment epithelium. The entire organelle is renewed in ϳ10 days in both mice and X. laevis. (6) . In X. laevis, which have much larger photoreceptors than humans, this requires the synthesis of an average of 2.3 m of ROS length per day per cell, equivalent to 3.2 m 2 of membrane per min per cell (6, 7) . Rhodopsin synthesis occurs in the RIS, and newly synthesized rhodopsin is transported to the RIS plasma membrane near the base of the connecting cilium and then to the site of new disc formation in the ROS, most likely via the connecting cilium plasma membrane. The high rates of membrane synthesis in photoreceptors make this an attractive cell in which to study membrane trafficking and transport (8, 9) . However, photoreceptors in cell culture systems quickly lose their ROS and do not divide (10) .
Over the past decade, a number of mutations in the rhodopsin gene were identified as causes of retinitis pigmentosa, a group of hereditary retinal degenerative diseases characterized by progressive loss of vision (11) . Extensive studies of mutant rhodopsins by expression in mammalian cells or transgenic animals have demonstrated that some mutations may affect the processes of rhodopsin folding and transport to the ROS (9, (12) (13) (14) (15) (16) . For example, studies in both transgenic mice and X. laevis suggest that mutations of the C-terminal region of rhodopsin disrupt a ROS localization signal (9) , resulting in delocalization to the RIS plasma membrane (9, 15) . These mutations provide further impetus for understanding rhodopsin targeting and transport.
We constructed a fluorescent form of rhodopsin, rho-GFP, a fusion protein of bovine rhodopsin (rho) and green fluorescent protein (GFP). We first examined the properties of rho-GFP expressed in COS-1 cells and found that it bound retinal, forming a functional light receptor. Like bovine rhodopsin, rho-GFP expressed in COS-1 cells localized to the plasma membrane. Affinity-purified rho-GFP activated transducin, with a maximal activity approximately half that of rhodopsin. The level of rho-GFP phosphorylation by rhodopsin kinase was about 10% of that of native rhodopsin phosphorylation. Thus, rho-GFP retained many features of native rhodopsin despite the addition of a large fluorescent tag that nearly doubled its mass.
To visualize physiological events associated with rhodopsin biogenesis in intact cells, we employed an in vivo approach and examined the subcellular distribution of rho-GFP expressed in transgenic X. laevis rod photoreceptors. The large size and turnover rates of amphibian photoreceptors, as well as the relative ease with which transgenic X. laevis can be generated, are reasons for studying rhodopsin transport in frogs. Here we describe transgenic X. laevis that express rho-GFP and a rho-GFP variant with a localization defect and demonstrate that the transgenic X. laevis rho-GFP approach is useful for monitoring gene expression and protein transport in photoreceptors.
Our study revealed an interesting variegated expression pattern, which is probably analogous to position-effect variegation (PEV). PEV describes a mosaic expression pattern in a genetically non-mosaic animal that is dependent on localization of a gene within or adjacent to regions of heterochromatin (17, 18) . Many of our transgenic animals exhibited PEV-like expression patterns. Because the daily renewal of ROS membranes effectively provides a 10-day record of expression levels, we were also able to discover that transgene expression varied not only between cells but also within individual cells on time scales ranging from days to hours, resulting in narrow bands of rho-GFP in the ROS. This temporal variation was not synchronized across the retina, but rather each cell expressed rho-GFP independently at different times. Temporal variation of expression levels has implications for mechanisms of PEV, transgenic models of retinal degeneration, and other transgenic animal systems.
EXPERIMENTAL PROCEDURES

Construction of rho-GFP and Expression Plasmids
For the construction of the rho-GFP cDNA, SalI sites were created at the 5Ј and 3Ј ends of the enhanced GFP cDNA by polymerase chain reaction, using eGFP-C1 (CLONTECH) as a template. This modified cDNA was inserted into the SalI site of the synthetic bovine rhodopsin cDNA in the pMT4 expression vector (19) . The resulting construct encodes a fusion protein in which eGFP was inserted in the C-terminal domain of rhodopsin, and Ser-334 and Thr-335 of rhodopsin are present before and after the inserted GFP (amino acids 2-240) (Fig. 1) . DNA sequencing confirmed the correct orientation of the inserted GFP cDNA. The rho-GFP⌬CT cDNA was constructed by replacing the SalI/ NotI fragment of the synthetic bovine rhodopsin cDNA in pMT4 with the SalI/EcoRI fragment of eGFP-N1 (CLONTECH), containing the eGFP cDNA, resulting in a cDNA encoding a fusion protein lacking the extreme C terminus of rhodopsin. The pMT-based plasmids were used for expression in COS-1 cells. For expression in transgenic X. laevis rods, the mammalian expression vector pCDNA1.1/AMP (Invitrogen) was digested with SpeI, releasing the CMV promoter, and a linker containing a BamHI site (CTAGTGGATCCA) was ligated into the SpeI site. The 5.5-kb BamHI fragment containing the previously described X. laevis opsin promoter (20) was cloned into the new BamHI site to create the vector pCDNA-XOP. Digestion with PstI confirmed the correct orientation of the promoter. EcoRI-NotI fragments of pMT plasmids containing the rho-GFP and rho-GFP⌬CT cDNAs were ligated into the multiple cloning site of pCDNA-XOP to create the expression plasmids pcDNA-XOP-rho-GFP and pcDNA-XOP-rho-GFP⌬CT.
Expression of rho-GFP in COS-1 Cells and UV-Visible
Absorption Spectroscopy rho-GFP was expressed in COS-1 cells by transient transfection with a DEAE-dextran method (21) . Cells were incubated with 11-cis retinal (2 M) 48 h after transfection for 1 h at room temperature. Cells were solubilized in 1% dodecyl maltoside in 50 mM Tris-HCl, 150 mM NaCl, pH 7.5 in the presence of 0.1 mM phenylmethylsulfonyl fluoride at 4°C for 1 h. rho-GFP was purified using anti-rhodopsin monoclonal antibody 1D4 coupled to Sepharose as described previously (22) . UV-visible absorption spectra of purified rho-GFP were recorded on a PerkinElmer Lambda 14 UV-visible spectrophotometer. Bleaching spectra were obtained by illuminating the sample through a 550-nm long pass cutoff filter.
FIG. 1. Schematic structure of rho-GFP. GFP was inserted into the C-terminal tail of rhodopsin. A, the original sequence of the C-terminal 23 amino acids of bovine rhodopsin is shown. The positions of residues 334, 335, and 348 (C terminus) are identified. Because of the methodology of generating the fusion protein, residues 334 and 335 are duplicated in rho-GFP. B, the sequences of the rhodopsin-GFP and GFP-rhodopsin junction regions are illustrated. The duplicated amino acids are underlined. The rhodopsin sequence is shown in solid font, and the GFP sequence is shown in outlined font. The dashed line indicates intervening sequences not illustrated. The rho-GFP⌬CT fusion protein lacks the C-terminal 15-amino acid region of rhodopsin. C, a cartoon model of rho-GFP based on the previously described structure of rhodopsin. The GFP domain is predicted to lie on the cytoplasmic side of the disc membrane. The extreme C terminus of rhodopsin is still present and free to act as a transport signal.
Transducin Activation by rho-GFP
Transducin was purified from bovine retina, and the ability of rho-GFP to activate transducin was determined by a [
35 S]GTP␥S guanine nucleotide exchange assay as previously described (23) . In brief, the reaction (500 l) contained 1 nM rho-GFP or rhodopsin purified from COS-1 cells, 1 mM transducin, 2 mM [
35 S]GTP␥S, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 5 mM ␤-mercaptoethanol, and 0.012% dodecyl maltoside. Aliquots (80 l) of the reaction mixture were removed at the indicated times, and [
35 S]GTP␥S bound to transducin was determined by a filter binding method.
Light-dependent Phosphorylation of rho-GFP by Rhodopsin Kinase
A crude extract enriched for rhodopsin kinase was prepared from bovine ROS, and a phosphorylation assay was carried out essentially as described (24) . In brief, the reaction mixture containing 126 pmol of rho-GFP or rhodopsin purified from COS-1 cells, 350 l of rhodopsin kinase extract, 100 mM [␥-
32 P]ATP, 3 mM MgCl 2 , 150 mM dithiothreitol, 10 mM GTP, and 0.012% dodecyl maltoside in 70 mM NaH 2 PO 4 , pH 7.0 was illuminated through a 550-nm long pass filter at room temperature. At time intervals, aliquots (150 l) were removed, and the proteins were precipitated with 3% trichloroacetic acid. Precipitated proteins were washed with 3% trichloroacetic acid in 5 mM phosphoric acid five times and dissolved in Soluene 350 (Packard), and radioactivity was measured in a scintillation counter. Additionally, an aliquot (20 l) was removed from the reaction and subjected to 10% SDS-polyacrylamide gel electrophoresis, and light-dependent phosphorylation was analyzed by autoradiography.
Expression of rho-GFP in X. laevis Rod Photoreceptors and Generation of F1 Offspring
Transgenic X. laevis were generated by the method of sperm nuclear transplantation into unfertilized eggs as described by Kroll and Amaya (25) , with minor modifications as previously described (26) . The restriction enzyme NheI was used to linearize the plasmid for transgenesis, as well as for restriction enzyme-mediated integration. Within 5-7 days after injection, transgenic animals were identified visually by examining fluorescence from their eyes using a dissecting microscope equipped with fluorescence optics and a GFP filter set. Tadpoles were raised at 18°C on a 12-h light/12-h dark cycle. Transgenic X. laevis that reached maturity were bred with wild-type adults to obtain F1 offspring.
Cellular Localization of rho-GFP
In COS-1 Cells-COS-1 cells were grown on glass coverslips and transfected as above. After 48 h, cells were fixed in phosphate-buffered saline, pH 7.2 containing 4% paraformaldehyde and 0.1% glutaraldehyde. Intracellular localization of rho-GFP was examined with a Zeiss 410 confocal microscope using a 488-nm laser band and a 515-540 band-pass filter to visualize rho-GFP.
In Transgenic X. laevis Eyes-Tadpole eyes were fixed in 0.1 M sodium phosphate buffer, pH 7.4 containing 4% paraformaldehyde at 4°C overnight. Eyes were embedded in OCT medium (Tissue Tek), and 14-m cryosections were prepared. Cryosections were stained with Texas Red-conjugated wheat germ agglutinin (Molecular Probes) and Hoechst 33342 (Sigma) as previously described (9) . Sections were observed with a Zeiss 410 confocal microscope.
Quantitation of rho-GFP Expression in Transgenic X. laevis Rods
The expression level of rho-GFP in Xenopus rods was determined by quantitative confocal microscopy, using a method similar to that described by Piston et al. (27) . Eyes were fixed in 0.1 M sodium phosphate buffer, pH 7.4 containing 4% paraformaldehyde at 4°C for 30 min and transferred to phosphate-buffered saline. Cryosections were prepared as described above. Unstained sections were mounted in phosphatebuffered saline, and fluorescence images were gathered using a Zeiss 410 confocal microscope equipped with a Zeiss ϫ 40 numerical aperture 1.3 water immersion objective, which minimized variation in signal due to depth of confocal sectioning. Pinholes were adjusted to give 1-m optical sections. Standard curves were generated from images of diluted recombinant GFP standards (CLONTECH) taken under identical conditions. The concentration of rho-GFP in transgenic X. laevis rods was measured by matching the intensity of the green fluorescence obtained from the retinal sections to the standard curves. To test the effect of fixation on GFP fluorescence, samples of recombinant GFP were mixed with 10 volumes of paraformaldehyde fixative, incubated for 30 min, diluted 100-fold in phosphate-buffered saline, and immediately examined using the confocal microscope. Treatment with formaldehyde fixative lowered GFP fluorescence by 20% (accounting for dilution). Therefore, measurements reported were corrected for this reduction. Image analysis was performed on a Macintosh computer using the public domain NIH Image program (developed at the United States National Institutes of Health and available on the Internet.)
Preparation of Genomic DNA and Southern Blotting
Genomic DNA was isolated from individual primary transgenic tadpoles at 14 days post-fertilization (stage 50) or from 50 randomly selected 3-4-day post-fertilization F1 embryos of transgenic founders crossed with wild-type frogs. Tadpoles or embryos were incubated in a solution containing 150 mM NaCl, 10 mM EDTA, pH 8.0, 1 mg/ml proteinase K, and 1% SDS overnight at 55°C. DNA was extracted from this solution and treated with RNase and proteinase K as described (28) . For Southern blots either 5 g of embryo DNA or one-third of the DNA yield from a single tadpole was digested with EcoRI and subjected to electrophoresis on a 0.7% agarose gel. DNA fragments were transferred to a Hybond Nϩ membrane and hybridized with a digoxigenindUTP-labeled probe as described (29). The hybridized probe was detected using the DIG luminescent detection kit for nucleic acids (Roche Molecular Biochemicals). The probe was prepared by polymerase chain reaction using the oligonucleotide primers TGGGGTCTTTGCTCAGG and ATGAACGGTACCGAAGGC and spanned the unique EcoRI site of the transgene construct corresponding to the translation start site of rho-GFP.
RESULTS
Expression of rho-GFP in COS-1 Cells
Rho-GFP Folds Correctly and Binds 11-cis Retinal-To determine whether the fusion protein folded correctly, rho-GFP was expressed in COS-1 cells, and the regeneration of rhodopsin with exogenously added 11-cis retinal was examined. rho-GFP generated a distinct pigment with the spectral properties of both rhodopsin (A max at 500 nm) and GFP (A max at 488 nm), as shown in Fig. 2 . The two independent chromophores were clearly seen in the dark-light difference spectra. On the basis of the amounts of the purified proteins, the expression level of rho-GFP in COS-1 cells was estimated to be 40 -60% of that of wild-type rhodopsin. Purified rho-GFP was N-glycosylated, because the electrophoretic migration of the purified protein was accelerated by digestion with endoglycosidase F (see Fig. 5C ).
The spectral ratio of 280 nm to 500 or 488 nm of rho-GFP was ϳ2. Because the spectral ratio of 280 -488 nm of GFP alone is ϳ1.6, and the spectral ratio of 280 -500 nm of purified rhodopsin expressed in COS-1 cells is 1.6 -2.0, the spectral ratio of rho-GFP indicated that the majority of expressed rho-GFP was folded and bound 11-cis retinal. Consistent with this finding, rho-GFP was transported to the plasma membrane of COS-1 cells (Fig. 3) as previously reported for rhodopsin (22) .
rho-GFP Activates Transducin but Is Inefficiently Phosphorylated-To examine how the inserted GFP altered the structure of the cytoplasmic regions of rhodopsin, the ability of rho-GFP to activate transducin and to undergo phosphorylation by rhodopsin kinase was studied. As shown in Fig. 4 , rho-GFP activated transducin at a rate of ϳ50% of the wildtype activity upon illumination, and the activation reached a plateau at ϳ50% of the wild-type level.
Insertion of GFP into the C-terminal tail of rhodopsin markedly reduced light-dependent phosphorylation by rhodopsin kinase. Quantification of phosphate incorporation using [␥-
32 P]ATP revealed that rho-GFP was phosphorylated at a level of 0.6 mol of phosphate/mol of rho-GFP in 1 h at room temperature, whereas rhodopsin was phosphorylated at a level of 2.7 mol of phosphate/mol of rhodopsin (Fig. 5A ). Approximately 0.2 pmol of phosphate/mol was incorporated into either rho-GFP or rhodopsin in the dark. An autoradiogram of the phosphorylated rhodopsin and rho-GFP is shown in Fig. 5B .
Expression of rho-GFP in X. laevis Rod Photoreceptors
Rho-GFP Is Expressed and Transported to the ROS in Transgenic X. laevis Rods-Using a fluorescence-equipped dissecting microscope, GFP fluorescence was detected in the eyes of ϳ30% of the tadpoles that developed from microinjected eggs. In a typical transgenesis experiment, 50 -100 transgenic tadpoles were generated from several thousand injected eggs. Fluorescence was detected 5-7 days after fertilization, corresponding to developmental stages 46 -48. Fluorescence gradually increased over 10 days, most likely reflecting the increasing size of the eye as well as the increasing length of the photoreceptors. A similar observation was made in X. laevis eyes expressing GFP (26) , but the increase in fluorescence was more prominent with animals expressing rho-GFP.
Evaluation of frozen sections of transgenic X. laevis eyes by fluorescence microscopy revealed that almost all rho-GFP was localized to the ROS organelle of the rod cells (Fig. 6A) . By greatly increasing the intensity of the excitation laser and the gain of the photomultiplier, a trace amount of rho-GFP was detected in the RIS membranes (Fig. 6C) . Rho-GFP was expressed specifically in major rod photoreceptor cells and was not found in minor rods or cone photoreceptors. In some sections, green fluorescence was detected within vesicle-like structures in the retinal pigment epithelium (Fig. 6A ). These may represent phagosomes containing recently shed ROS fragments. Retinal degeneration was not detected in any transgenic X. laevis expressing rho-GFP. We analyzed Ͼ1-year-old transgenic frogs, and the morphology of their retinas was still normal.
Rho-GFP⌬CT Delocalizes to Inner Segment MembranesPreviously, we demonstrated that the C terminus of rhodopsin contains a ROS localization signal (9) . Others have shown that deletions in the C terminus of rhodopsin lead to delocalization of rhodopsin to RIS plasma membranes (9, 15, 30) . To test whether similar effects could be observed with rho-GFP, we made transgenic X. laevis that expressed a rho-GFP deletion variant, rho-GFP⌬CT, in which the C-terminal 15 amino acid residues were eliminated (Fig. 1) . Expression levels of rho-GFP and rho-GFP⌬CT in X. laevis rods were similar (see below). However, confocal microscopy of frozen sections from transgenic X. laevis eyes showed that rho-GFP⌬CT was found not only in the ROS but was also delocalized to the plasma membrane and synapse of the RIS (Figs. 6B and 7D ). In contrast, no identifiable differences in localization were observed between rho-GFP and rho-GFP⌬CT expressed in COS-1 cells (Fig. 3) . Thus, rho-GFP expressed in X. laevis photoreceptors is a useful FIG. 2. UV-visible absorption spectra of purified rho-GFP expressed in COS-1 cells. A, independent spectra of rhodopsin (solid line, max at 500 nm) and GFP (dotted line, max at 488 nm) proteins were overlaid. B, spectra of rho-GFP. Spectra were recorded before (solid line) and after (dotted line) bleaching the sample using a 550-nm long pass filter. The GFP absorption peak is seen in the bleached spectrum. C, the dark-light difference spectra (rho-GFP spectrum minus bleached rho-GFP spectrum) clearly shows the regeneration of rhodopsin pigment from rho-GFP fusion protein and 11-cis retinal. basis for the analysis of mutations believed to interfere with rhodopsin targeting and transport.
Variable Expression of rho-GFP-The expression level of rho-GFP in X. laevis rod photoreceptors varied in a number of ways. First, visual inspection of green fluorescence from intact eyes showed that the expression level varied considerably among different transgenic tadpoles. Second, microscopic studies showed that the expression level varied from cell to cell within the same retina in most transgenic tadpoles. Third, in many of these cells, the expression of rho-GFP varied with time, because the green fluorescence was observed in banded patterns in the ROS. The bands were not synchronous but irregularly spaced within each ROS and relative to other ROS. Only a small proportion of tadpoles expressed rho-GFP in a relatively uniform manner throughout the retina and throughout each ROS. Confocal micrographs of frozen sections of eyes from several different transgenic tadpoles are shown in Fig. 7 , A-C to illustrate these findings. This variable expression was found in both primary transgenics and in their F1 offspring and therefore is not a consequence of late integration of the transgene generating a genetically mosaic animal.
To quantitate the expression levels of rho-GFP, the concentration of rho-GFP in ROS was determined by confocal microscopy. Quantitative experiments were performed on six transgenic tadpoles expressing rho-GFP, two transgenic tadpoles expressing rho-GFP⌬CT, and one transgenic tadpole expressing GFP under the control of the same promoter. Fusion protein concentrations were measured in at least four ROS from each animal. In a tadpole expressing rho-GFP at relatively high levels and throughout all ROS (Fig. 7A) , the measured expression level varied between 5.5 and 13 M, with an average value of 9.4 M. For comparison, the concentration of endogenous rhodopsin in amphibian photoreceptors is estimated to be 2.5-3.5 mM (3, 4) . On the basis of these values, the expression level of rho-GFP in this tadpole was ϳ0.3% of the level of endogenous X. laevis rhodopsin. For the other five tadpoles (which expressed rho-GFP at lower levels and irregularly; see Fig. 7 , B, C, and E), the concentration was determined from banded fluorescent regions (Fig. 7, E and F) . The peak concentrations of rho-GFP within the bands ranged from 0.4 to 9.5 M, corresponding to peak expression levels of 0.01-0.3% of endog- GTP␥S to transducin at levels ϳ50% lower than those of wild-type rhodopsin obtained by identical means from COS-1 cells, but substantially greater than those of control samples of rhodopsin and rho-GFP that were not light activated. enous rhodopsin. The expression level of rho-GFP⌬CT was also examined. In the two animals investigated, which had relatively uniform expression patterns, ROS fusion protein concentration varied between 1.8 and 2.8 M, or 0.06 -0.09% of endogenous rhodopsin. This concentration was similar to or lower than expression levels measured for rho-GFP, indicating that the delocalization of rho-GFP⌬CT was not due to higher expression levels of this fusion protein. Banded patterns of fluorescence were also observed in many rho-GFP⌬CT animals (data not shown). Finally, the expression level of GFP was investigated. The distribution of GFP expressed in X. laevis rods has been previously described. Unlike rho-GFP, GFP accumulates to the highest concentrations in the RIS, and ROS levels are about one-fifth of RIS levels (26) . RIS GFP levels were examined in one animal (the F1 offspring of transgenics described by Moritz et al. (26) ) and found to greatly exceed the most concentrated GFP standard available (1.0 mg/ml or 37 M). However, assuming a linear response of the photomultiplier detector (27), we extrapolated GFP levels at 190 M, a concentration ϳ6% of that of endogenous X. laevis rhodopsin.
Numbers of Transgene Integration Sites and Transgene Arrangements-The numbers of integration sites in two male transgenic X. laevis founders (␤ and ␥) were studied by genetic and Southern analyses. In the genetic approach, the founders were bred with non-transgenic females, and the percentage of F1 offspring with fluorescent eyes was determined. 50% (174/ 345) and 46% (129/282) of offspring of ␤ and ␥, respectively, were transgenic by this test, suggesting that both founders had a single functional integration site. Southern blots were then performed on EcoRI-digested genomic DNA isolated from individual F1 tadpoles and pooled F1 DNA (Fig. 8) . The probe used spanned a unique EcoRI site located between the promoter and the rho-GFP cDNA. Therefore, a single integration site with a single copy of the construct would be expected to produce two bands. A third band due to hybridization to the endogenous X. laevis opsin promoter would be expected in control as well as transgenic DNA. However, Southern blots of F1 offspring contained numerous bands relative to control DNA (Fig. 8, A and  B) , suggesting that multiple copies of the transgene construct Green fluorescence was primarily restricted to the outer segments (OS) of rod photoreceptors. Green fluorescence was not observed in cone photoreceptors and minor rods (white arrows). Occasional fluorescence was observed within the pigment epithelium (RPE) (white arrowhead), possibly representing phagosomes. C, the rho-GFP signal from a transgenic retina in which expression levels varied considerably from cell to cell. The sensitivity of detection was increased until the rho-GFP signal was saturating in the outer segments, demonstrating that trace amounts of rho-GFP could be detected in the inner segments (IS) (arrows). This level of sensitivity also detected autofluorescence (AF) from ROS of cells that did not express significant levels of rho-GFP. Bars, 10 m.
FIG. 7.
Variation in expression patterns of rho-GFP observed in transgenic X. laevis retinas and determination of expression levels by quantitative confocal microscopy. The green signal indicates the expression of rho-GFP. The sections were counterstained with Texas Red-conjugated wheat germ agglutinin (glycosylated membranes, red) and Hoechst 33342 dye (nuclei, blue). Overlap of green and red makes the rho-GFP signal appear yellow. A, in some retinas, the majority of photoreceptors expressed rho-GFP in a relatively uniform pattern throughout the ROS. B and C, in the majority of retinas a banded pattern of expression was observed. The size and spacing of the bands varied from cell to cell and from retina to retina and were not synchronized across the retina. D, in retinas that expressed the rho-GFP⌬CT fusion protein, green fluorescence delocalized to the inner segment plasma membrane and synapse, as well as some internal membranes, indicating a defect in trafficking of this fusion protein to the ROS. Expression levels of rho-GFP and rho-GFP⌬CT were similar (see "Results"). E and F, demonstration of the determination of fusion protein concentration in ROS using quantitative confocal microscopy. Confocal micrographs (E) were calibrated to recombinant GFP standards using NIH Image software. Plots of fusion protein concentration along ROS axes (F) were obtained from calibrated micrographs. Plots in F are derived from the micrograph shown in E, along lines w-x and y-z. The x axis is related to time by the approximate relationship 1 m ϭ 10 h. Bars, 10 m.
were integrated. All fluorescence-positive offspring of founder ␥ produced an identical complex hybridization pattern (Fig. 8A) , indicating that multiple copies of the transgene were integrated into a single site in the X. laevis genome, in agreement with the genetic results. Fluorescence-negative offspring all showed a single weak band, the result of hybridization of the probe to the endogenous rhodopsin promoter. In contrast, offspring of transgenic tadpole ␤ produced several different hybridization patterns (Fig. 8B ) in both fluorescence-negative and fluorescence-positive animals, indicating that the transgene integrated into more than one site in the genome. The hybridization to transgene sequences in DNA from fluorescence-negative offspring suggests that some integration sites may be nonfunctional or intermittently functional.
We also performed Southern blots on genomic DNA samples prepared from pools of 50 F1 embryos of ␤ and ␥ randomly selected before identification of transgenic animals by fluorescence was possible. These genomic DNA samples therefore represent the average genomic content of each founder diluted with an equal quantity of non-transgenic DNA. Because we were able to obtain large quantities of DNA by this method, these blots were of higher quality (Fig. 8C) . The hybridized bands represent all bands seen in blots of individual offspring (Fig. 8, A and B) . Bands of high intensity are likely to be due to integration sites containing multiple copies of the transgene, for example as head-to-head, head-to-tail, or tail-to-tail concatamers. Such integrations would produce restriction fragments of defined sizes. For example, a head-to-tail integration would produce an additional band identical in size to the original construct (11.3 kb), whereas other bands would appear at 14.5 kb (head-to-head) and 8.2 kb (tail-to-tail), because the EcoRI site was 7.2 kb from one end of the linearized construct. On Southern blots, such bands derived from integration sites containing numerous repeats of the transgene construct would be relatively intense in comparison to the two uniquely sized bands derived from each integration site or the band representing the endogenous gene (see previous paragraph). High intensity bands were apparent in Southern blots of DNA prepared from both ␤ and ␥ offspring (Fig. 8C) , indicating that single integration sites contained multiple copies of the transgene construct. In blots of ␥ F1 offspring DNA, the intense bands were of the sizes predicted for concatamers. However, in blots of ␤ F1 offspring DNA, an intense band appears at 4.5 kb, indicating that other integration arrangements can occur.
DISCUSSION
Rho-GFP shares many of the properties of native rhodopsin. The insertion of GFP in the C-terminal tail of rhodopsin (Fig. 1) had little effect on protein folding, as determined by pigment/ fluorophore generation with 11-cis retinal, green fluorescence, and cellular localization in COS-1 cells. Previous studies (12) (13) (14) 31) indicate that the C-terminal domain is most suitable for such a modification, despite its involvement in post-Golgi transport of rhodopsin (8, 9, 32, 33) . However, the insertion of GFP did affect some properties of rhodopsin. Light-dependent phosphorylation of rho-GFP by rhodopsin kinase was significantly reduced relative to rhodopsin, whereas the ability of rho-GFP to activate transducin was less affected. Activation of   FIG. 8. Southern blot analysis of  transgenic X. laevis. A, Southern blots of EcoRI-digested genomic DNA from individual 10-day-old offspring of founder ␥ that were screened for fluorescence. The probe used spanned the unique EcoRI site of the transgenesis construct, between the 3Ј end of the X. laevis opsin promoter and the 5Ј region of the rho-GFP transgene sequence. Only one banding pattern was seen in animals scored positive for fluorescence (␥ϩ), and only the band derived from the endogenous opsin promoter was seen in animals scored negative (␥Ϫ). This suggests a single integration site containing multiple copies of the transgene that was functional in all animals. B, a similar experiment was performed with offspring of founder ␤. Several different banding patterns were observed, suggesting that the transgene integrated at multiple sites in the genome. Bands corresponding to transgene integrations were found in animals scored both positive (␤ϩ) and negative (␤Ϫ) for fluorescence, suggesting that some integration sites were nonfunctional or intermittently functional. C, to obtain Southern blots more representative of the founders, genomic DNA was prepared from 50 unscreened 4-day-old F1 embryos of ␤ and ␥ transgenic founders and subjected to similar Southern blot analysis using a larger format gel. Multiple bands were labeled in DNA derived from both founders. Dark bands are most likely derived from integrations consisting of multiple repeats of the transgene construct. DNA from nontransgenic animals was included as a control (nt). Only a single band arising from the endogenous rhodopsin gene was labeled in non-transgenic DNA. The positions of the linearized vector (V) and the endogenous rhodopsin gene (E) are indicated on all blots. transducin and phosphorylation of the C-terminal tail of rhodopsin involve the interaction of rhodopsin cytoplasmic loops with transducin or rhodopsin kinase, respectively (34 -38) . Our results suggest that there is a partial perturbation of the cytoplasmic structure of rhodopsin, most likely resulting from steric hindrance by the ␤-barrel of GFP. The three-dimensional structure of the rhodopsin C-terminal peptide determined by nuclear magnetic resonance spectroscopy shows that the site of insertion of GFP is oriented outward and support this interpretation of our data (39, 40) . Compared with transducin activation, the more significant reduction in the level of phosphorylation may reflect a large spatial displacement of the C-terminal tail containing the multiple phosphorylation sites. One possibility is that the residue equivalent to rhodopsin serine 334 (on the N-terminal side of GFP in the fusion protein; shown in Fig. 1C) , which has been previously suggested to be one of the initial phosphorylation sites (41), may be phosphorylated at a very low level. Our results therefore suggest that rho-GFP possesses many, but not all, of the structural and functional characteristics of rhodopsin.
Transgenic X. laevis were generated by the restriction enzyme-mediated integration method recently developed by Kroll and Amaya (25) . This simple and relatively inexpensive technique was used previously to express GFP and GFP fusion proteins in the principle rod cells of X. laevis using the X. laevis principal opsin promoter (20) . Rapid production of transgenic tadpoles and the generation of large numbers of independent transgenic lines is achievable (9, 26, 42) . In this study, expression of rho-GFP in principal rods of X. laevis generated tadpoles with green fluorescent eyes, similar to previous studies with expression of GFP (26, 42) , although the eyes of animals expressing rho-GFP were much less fluorescent. Like endogenous rhodopsin, rho-GFP was almost exclusively localized to ROS membranes, in contrast to GFP alone, which was found mostly in the cytoplasm and nucleoplasm of the inner segment (26, 42) . Thus, the exact spatial position of the C-terminal ROS localization signal is not critical for the transport of rhodopsin to the ROS, as long as the native sequence is present and is accessible to the sorting pathway components.
We compared the localization of rho-GFP to a rho-GFP variant, rho-GFP⌬CT, in which the C-terminal 15 amino acid residues of rhodopsin were deleted. This variant had a distribution indistinguishable from rho-GFP when expressed in COS-1 cells. By contrast, when rho-GFP⌬CT was expressed in transgenic frog rods under conditions identical to those used for rho-GFP, it delocalized to the lateral plasma membrane of the inner segment and synapse. This parallels results previously described by others in transgenic mice, in which the distribution of C-terminal deletion mutants of rhodopsin was examined (15, 30) . The delocalization does not appear to be a result of overexpression, because expression levels of rho-GFP⌬CT were low relative to endogenous rhodopsin and were comparable with or lower than those measured for rho-GFP. Therefore, rho-GFP provides a useful starting point for the analysis of mutations that may affect the intracellular trafficking or transport of rhodopsin. Such experiments would be more easily carried out than experiments using transgenic mice (15) and physiologically more relevant than experiments using cultured cells, in which an identified rhodopsin sorting signal (9) does not function (22, 43; Fig. 3 ). Furthermore, it may be possible to examine the transport of fluorescent fusion proteins in living cells using vibratome sections or dissociated retinas.
In many of the transgenic tadpoles, expression levels varied considerably among individual cells within the same retina. This cell-to-cell variation is similar to that previously reported by Zack et al. (44) and by Lem et al. (45) in transgenic mice expressing lacZ under control of the bovine or mouse opsin promoters. Zack et al. (44) speculate that the mechanism underlying the variation may be similar to PEV originally seen in Drosophila (17, 46) . PEV refers to a nonuniform or mosaic expression pattern of a gene within cells of a given type. The variability is dependent on the chromosomal location of the gene, often within or adjacent to regions of heterochromatin (17, 18) . PEV is seen with a variety of transgenesis methods, including microinjection of the transgene into blastulas (mice) and the use of transposable p-elements (Drosophila). Our results are unique because we show not only cell-to-cell variation but also variation within the same cell over periods on the order of hours or days.
It is unlikely that these results reveal a normal function of the rhodopsin promoter. Although the rate of ROS disc synthesis varies on a diurnal cycle (6), the variation we observed does not follow a diurnal pattern. Bands of varying birefringence of unknown origin that may relate to the periodicity of disc membrane synthesis can be seen in ROS using polarization optics, but these bands are regularly spaced and are governed by the phase of the light/dark cycle during which they were formed (47) . Instead, our results suggest an artifact of the transgenesis procedure. It is interesting to note that this is probably the first case in which transgene expression levels have been tracked within individual cells of a transgenic animal over the course of ϳ10 days (the length of time represented by an intact ROS). We previously observed occasional extreme cell-to-cell variation with eGFP expressed from the same promoter fragment (26) , but this occurred in a minority of cases, and we attributed it to late integration of the transgene construct creating genetically mosaic primary transgenic animals. However, it is possible that the long intracellular half-life of eGFP masked the majority of the variation, so that only the most extreme cases were observed.
It is not clear whether the PEV-like expression patterns observed in our system and other systems are created by the same mechanisms, but there is no apparent reason to suspect otherwise. The underlying mechanisms of PEV have not been well characterized, and there are probably multiple sources of PEV in higher eukaryotes (18) . One explanation is that transgenes are introduced into, or close to, regions of condensed heterochromatin. It is hypothesized that such transgenes alternate between a condensed inactive state and a decondensed active state as heterochromatin/euchromatin boundaries drift (17) . It is possible that the restriction-mediated integration methodology we employed is somehow selective for these regions. Alternatively, the presence of transgene concatamers at each integration site may induce a heterochromatin-like state (48) . Another possible source of PEV is elimination of regions of DNA containing the transgene in differentiated cells, resulting in clones of cells in which the transgene is deleted. Clearly this is not the source of variegation in our tadpoles, because cells alternate between expressing and non-expressing states. Finally, if gene-insulating elements are not present, position effects may occur because of transcription control mechanisms associated with nearby genes. Inclusion of gene boundary-defining or -insulating elements such as matrix attachment or locus control regions in the transgene construct might eliminate sources of PEV associated with heterochromatin or gene regulation (49, 50) .
Our results demonstrate that the mechanisms of gene silencing that produce PEV-like expression patterns are not static within a given cell but vary over short periods of time. Previously, Milot et al. (51) provided evidence for two forms of PEV in transgenic mouse erythroid cells, in which transgene expression either varies temporally within individual cells or is sto-chastically on or off in groups of cells. They showed that both forms were linked to integration into pericentromeric heterochromatin and speculated that variable expression might be linked to the cell cycle, with transgenes expressed during decondensation of heterochromatin. However, neither the cell cycle nor extracellular environmental factors appear to influence PEV in our retinas. Because photoreceptors are terminally differentiated cells that do not divide, rho-GFP expression could not have been influenced by the cell cycle. Furthermore, adjacent cells with very similar environments did not have similarly timed expression patterns. Therefore, it is unlikely that PEV was produced by temporal or hormonal control of adjacent genes.
By using genetic and Southern analysis, we examined the arrangement of transgenes in two transgenic X. laevis founders. Our results show that in transgenic X. laevis generated by the method of Kroll and Amaya (25) multiple copies of transgene constructs can be present in tandem arrays at each integration site. Founder ␤ had multiple integration sites; however, the genetic ratios obtained in F1 offspring were consistent with only one of these being functional. Most likely, the individual integration sites functioned so intermittently that animals inheriting a single integration site were frequently scored as negative. Previously, Dorer and Henikoff (48) demonstrated that transgene concatamers can be associated with PEV in Drosophila, possibly by inducing formation of a heterochromatin-like state. Therefore, procedural modifications to reduce transgene concatamerization might be effective in reducing variegation.
Many mouse models of inherited retinal degeneration have been developed in which mutant versions of photoreceptor proteins such as rhodopsin or peripherin/rds are expressed in transgenic retinas (52) . PEV has been previously demonstrated in mice expressing lacZ from the bovine and mouse opsin promoters (44, 45) as well as other tissue-specific promoters (51, 53) . Therefore, researchers who deal with transgenic animal models of retinal degeneration or other genetic disorders should be aware that PEV could complicate their models. Conceivably, phenotypes could be generated that are due to atypical transgene expression patterns and not to the introduced mutation. Because expression of transgenes may vary dramatically from cell to cell, and even within the same cell over short periods of time, transgene expression must be examined by immunohistochemistry to verify that average expression levels obtained by western or Northern blot analysis are representative of individual cells. However, it is not clear how rapid changes in transgene expression levels within individual cells could be easily monitored in other cell types that lack a compartment such as the ROS that can report such variation.
We found the expression level of rho-GFP in photoreceptor cells to be markedly less than that of endogenous rhodopsin, as measured by quantitative confocal microscopy. The expression level of rho-GFP generally peaked at levels that were only a fraction of a percent of that of endogenous rhodopsin. However, levels of fusion protein in the majority of the ROS membranes in most retinas were low or undetectable, and therefore overall expression levels averaged over the entire retina were much lower. In agreement with the low measured levels of transgene product, we were unable to detect transgene expression in F1 offspring by either western or Northern blot under conditions that allowed us to reproducibly detect endogenous rhodopsin protein and mRNA (data not shown). In contrast, the level of eGFP expression from the same promoter was found to be more than an order of magnitude higher, although still substantially lower than the expression level of rhodopsin. Thus, the X. laevis principal opsin promoter is capable of driving high levels of transgene expression, and the relatively low expression level of rho-GFP may be due to specific features of the fusion protein, such as poor folding kinetics leading to degradation of nonfluorescent protein, or an unstable mRNA.
Retinal degeneration was not observed in the majority of these X. laevis, although it may develop as the animals grow older. Severe retinal degeneration was observed in one rho-GFP⌬CT primary transgenic; however, because this result was not reproducible, it is unclear whether the retinal degeneration was specifically caused by the mutant transgene or by transgene expression at all. One plausible reason for the lack of retinal degeneration is that levels of rho-GFP and rho-GFP⌬CT expression were low compared with those of endogenous X. laevis rhodopsin. In studies of transgenic mice, Olsson et al. (54) report that overexpression of wild-type human rhodopsin causes retinal degeneration, whereas lower expression levels do not affect rod cell physiology and viability. The C-terminal tail of rhodopsin contains a ROS localization signal (9) that plays a critical role in sorting to correct post-Golgi membranes (8, 32, 33) , and missense or deletion mutations in this region lead to retinal degeneration in humans and transgenic mice (11, 15, 30, 55) . It is likely that levels of mutant proteins or transgene products that are toxic to human rods and transgenic mouse rods would also be toxic to transgenic Xenopus rods. Therefore, it may be possible to generate models of retinal degeneration using our rho-GFP/X. laevis system if expression levels can be increased and made more uniform.
We have demonstrated that rho-GFP is a highly sensitive marker protein with many biochemical properties of rhodopsin that also behaves like native rhodopsin in transgenic X. laevis rods. Low levels of rho-GFP appear to be nontoxic to photoreceptors. This system will allow us to study physiological events involved in rhodopsin transport. With the use of various microscopy techniques, transgenic X. laevis expressing rho-GFP or rho-GFP mutants may provide a powerful means to study the expression and transport of rhodopsin and possibly the development of photoreceptor degeneration in vivo. These techniques could also be applied to the study of other ROS membrane proteins. The rho-GFP fusion protein also provides a unique opportunity to track levels of transgene expression in photoreceptors over time. Here we have demonstrated that PEV-like expression patterns can involve rapid variation in expression levels within individual cells, on timescales of days or hours. If the PEV-like variations can be eliminated or minimized, rho-GFP or other membrane-bound transgenes could also be used to monitor temporal or inducible regulation of promoters.
